NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.


ADVERTISMENT

ADVERTISMENT

Fip’s Practice Transformation Programme On Non-Communicable Diseases Turns Focus On Cancer

By irishpharmacist - 01st Nov 2022

cancer

Knowledge and skills recommended for pharmacists to practise cancer care are defined in new guidance from the International Pharmaceutical Federation (FIP) published recently. Such knowledge is not limited to the biology of cancer and cancer medicines, but includes public health strategies, non-pharmacological support, and communication. In addition to providing pharmacists with a comprehensive list of knowledge and skills, the new resource, ‘Knowledge and skills reference guide for professional development in cancer care’, aims to highlight key considerations for educators in the area of cancer to support pharmacists’ professional development. 

“The global burden of cancer is increasing and requires a more robust response from healthcare systems worldwide. The World Health Organisation has passed a resolution for cancer prevention and control, in the context of an integrated approach, to encourage countries to set goals, collect data and improve outcomes. By supporting pharmacists to develop, upskill and refresh knowledge in cancer care, FIP is empowering pharmacists to facilitate these goals,” said Dr Dalia Bajis, FIP lead for provision and partnerships and editor of the guidance document, which has been reviewed by a group of experts and contributed to by the European Society of Clinical Pharmacy. 

The new guidance is intended as a companion to ‘Cancer care — A handbook for pharmacists’, also published by FIP recently. This resource covers all aspects of cancer care for pharmacists, from prevention and screening, through treatment and management, to complications and end-of-life care. It, too, has been developed by an international expert advisory group and with the collaboration of the International Society of Oncology Pharmacy Practitioners. Dr Evelyn Handel, the Society’s president, writes in a foreword that oncology is an area where change is at its most rapid and that pharmacists are well poised to significantly implement many of the new treatments, technologies and research in cancer care. 

“This handbook and its accompanying knowledge and skills guide cover a lot of ground and provide a comprehensive foundation. . . I am excited for the impact [FIP’s Practice Transformation Programme on Non-Communicable Diseases] and accompanying resources will have on elevating the quality and consistency of oncology pharmacy practice globally,” Dr Handel commented.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist April 2024

Volume 25 | Issue 4 | April 2024. Read the latest issue of Irish Pharmacist here.

Read

OTC Update Spring 2024

Spring 2024 | Issue 1 | Volume 18. Read the latest issue of OTC Update here.

Read

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT